查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1712546

全球数位全像显微镜市场 - 2025-2033

Global Digital Holographic Microscopy Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球数位全像显微镜市场规模达到 4.766 亿美元，预计到 2033 年将达到 30.5689 亿美元，在 2025-2033 年预测期内的复合年增长率为 20.4%。

数位全像显微镜 (DHM) 是一种使用干涉结构进行定量相位成像 (QPI) 的流行技术。单元件干涉仪由于其简单、稳定和低成本而特别有用。一种称为单元件反射式数位全像显微镜（SER-DHM）的简单共路干涉布局使用单一一维衍射光栅来照明和产生数位全像图。本技术采用单次操作原理实现反射/不透明物体的 QPI 和形貌分析，并已通过实验验证。

市场动态：

驾驶员和约束装置

成像和显示技术的进步

由于成像和显示技术的进步，全球数位全像显微镜市场正在成长。相机解析度、光源、感光元件和即时影像处理的改进提高了DHM系统的性能、准确性和可用性。高速摄影机和高灵敏度探测器使研究人员能够以出色的清晰度和时间解析度捕捉动态生物过程。

3D显示技术和软体驱动的视觉化工具使得即时重建和解释复杂的全息资料成为可能，从而促进对标本进行更直观和互动的分析。这些进步扩展了 DHM 在细胞生物学、奈米技术和材料科学中的应用，在这些领域中，精确、无标记和定量成像至关重要。随着成像和显示技术的发展，有望降低技术复杂性和操作限制，使 DHM 在学术、临床和工业领域更易于存取和更具吸引力。

实施成本高

全球数位全像显微镜市场因实施成本高而面临挑战。先进的系统需要复杂的光学元件、高解析度摄影机和强大的资料处理软体，这会增加初始投资。整合到现有实验室可能需要基础设施改造和专门培训，进一步增加营运费用。这些成本可能会对预算有限的中小型研究机构或实验室造成障碍，减缓其广泛采用，尤其是在发展中地区或财政资源有限的组织中。

目录

第一章：市场介绍和范围

  • 报告目标
  • 报告范围和定义
  • 报告范围

第二章：高阶主管见解与关键要点

  • 市场亮点和战略要点
  • 主要趋势和未来预测
  • 显微镜类型的片段
  • 按应用程式截取的程式码片段
  • 最终用户的程式码片段
  • 按地区分类的片段

第三章：动态

  • 影响因素
    • 驱动程式
      • 成像和显示技术的进步
      • 对 3D 视觉化和分析的需求日益增长
    • 限制
      • 实施成本高
      • 技术挑战与局限性
    • 机会
      • 与扩增实境 (AR) 和虚拟实境 (VR) 的集成
    • 影响分析

第四章：战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有最大、最畅销品牌的成熟领导者
    • 拥有成熟产品的市场领导者
  • CXO 观点
  • 最新进展与突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态
  • 关键意见领袖

第 5 章：按显微镜类型

  • 传输DHM
  • 反射DHM
  • 离轴DHM
  • 内联 DHM

第六章：按应用

  • 生命科学
  • 材料科学
  • 半导体
  • 微电子
  • 其他的

第 7 章：按最终用户

  • 学术及研究机构
  • 製药和生物技术公司
  • 医院和诊所
  • 製造业

第八章：区域市场分析与成长机会

  • 北美洲
    • 关键区域特定动态
      • 我们
      • 加拿大
      • 墨西哥
  • 欧洲
    • 关键区域特定动态
      • 德国
      • 英国
      • 法国
      • 西班牙
      • 义大利
      • 欧洲其他地区
  • 南美洲
    • 关键区域特定动态
      • 巴西
      • 阿根廷
      • 拉丁美洲其他地区
  • 亚太
    • 关键区域特定动态
      • 中国
      • 印度
      • 日本
      • 韩国
      • 亚太其他地区
  • 中东和非洲
    • 关键区域特定动态

第九章：竞争格局与市场定位

  • 竞争概况和主要市场参与者
  • 市占率分析与定位矩阵
  • 策略伙伴关係、併购
  • 产品组合和创新的关键发展
  • 公司基准化分析

第十章：公司简介

  • Lyncee Tec
    • 公司概况
    • 产品组合
      • 产品描述
      • 产品关键绩效指标 (KPI)
      • 历史和预测产品销售
      • 产品销售量
    • 财务概览
      • 公司收入
      • 地区收入份额
      • 收入预测
    • 关键进展
      • 併购
      • 关键产品开发活动
      • 监管部门批准等
    • SWOT分析
  • Holoxica Limited
  • Phase Holographic Imaging AB
  • Ovizio Imaging Systems
  • Nanolive SA
  • Holmarc Opto-Mechatronics Ltd
  • DAEIL SYSTEMS CO., LTD

第 11 章：假设与研究方法

  • 资料收集方法
  • 数据三角测量
  • 预测技术
  • 数据验证和确认

第 12 章：附录

简介目录
Product Code: HCIT9511

The global digital holographic microscopy market reached US$ 476.60 million in 2024 and is expected to reach US$ 3056.89 million by 2033, growing at a CAGR of 20.4% during the forecast period 2025-2033.

Digital holographic microscopy (DHM) is a popular technique for quantitative phase imaging (QPI) using interferometric architectures. Single-element interferometers are particularly useful due to their simplicity, stability, and low cost. A simple common-path interferometric layout called single-element reflective digital holographic microscopy (SER-DHM) uses a single one-dimensional diffraction grating for illuminating and generating digital holograms. This technique enables QPI and topography analysis of reflective/opaque objects using a single-shot operation principle, which has been experimentally validated.

Market Dynamics: Drivers & Restraints

Advancements in Imaging and Display Technologies

The global digital holographic microscopy market is growing due to advancements in imaging and display technologies. Improvements in camera resolution, light sources, sensors, and real-time image processing have improved the performance, accuracy, and usability of DHM systems. High-speed cameras and high-sensitivity detectors enable researchers to capture dynamic biological processes with exceptional clarity and temporal resolution.

3D display technologies and software-driven visualization tools have made it possible to reconstruct and interpret complex holographic data in real-time, facilitating more intuitive and interactive analysis of specimens. These advancements have expanded DHM applications in cell biology, nanotechnology, and material science, where precise, label-free, and quantitative imaging is critical. As imaging and display technologies evolve, they are expected to reduce technical complexity and operational limitations, making DHM more accessible and appealing across academic, clinical, and industrial domains.

High Cost of Implementation

The global digital holographic microscopy market faces challenges due to high implementation costs. Advanced systems require sophisticated optical components, high-resolution cameras, and powerful data processing software, increasing initial investment. Integration into existing labs may require infrastructure modifications and specialized training, further increasing operational expenses. These costs can be a barrier for small- and medium-sized research institutions or labs with limited budgets, slowing widespread adoption, especially in developing regions or organizations with limited financial resources.

Segment Analysis

The global digital holographic microscopy market is segmented based on microscope type, application, end-user, and region.

Microscope Type:

The transmission DHM from the microscope type segment is expected to dominate the digital holographic microscopy market with the highest market share.

Transmission Digital Holographic Microscopy (DHM) is a sophisticated imaging technique that uses light transmission to capture holograms of microscopic structures. It records the phase shift of light waves, allowing for quantitative phase imaging and three-dimensional visualization without the need for dyes or labels.

The increasing demand for non-invasive imaging methods is driving the adoption of transmission digital holographic microscopy (DHM). This technique offers high-resolution, quantitative phase imaging of live cells, making it ideal for biomedical research, pharmaceutical development, pathology, cell biology, virology, and cancer diagnostics. It also supports long-term live-cell imaging without phototoxic effects, making it suitable for regenerative medicine and stem cell research. As academic institutions invest in high-end imaging systems, DHM adoption is expected to rise.

Geographical Analysis

North America is expected to hold a significant position in the digital holographic microscopy market, with the highest market share

North America is expected to dominate the global digital holographic microscopy market due to its advanced research facilities and healthcare infrastructure. The demand for non-invasive imaging techniques in biomedical research and clinical diagnostics has accelerated their adoption. Investments in nanotechnology, life sciences, and material science research, particularly in the US, are driving market growth. The presence of leading microscopy and imaging technology companies and government funding for R&D initiatives further enhances the market's expansion. The focus on precision medicine and real-time cellular imaging is expected to drive demand for digital holographic microscopy solutions.

For instance, in September 2024, Researchers have created a smartphone-based digital holographic microscope that offers precise 3D measurements, potentially expanding its applications to educational settings and point-of-care diagnostics in resource-limited settings.

Competitive Landscape

The major global players in the digital holographic microscopy market include Lyncee Tec, Holoxica Limited, Phase Holographic Imaging AB, Ovizio Imaging Systems, Nanolive SA, Holmarc Opto-Mechatronics Ltd, and DAEIL SYSTEMS CO., LTD, among others.

Key Developments

  • In March 2025, Honeywell introduced Digital Holographic Microscopy (DHM), a technology that uses artificial intelligence to efficiently count and classify microscopic particles or cells, offering significant potential in industries requiring rapid analysis and streamlined operations.

Why Purchase the Report?

  • Technological Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global digital holographic microscopy market report delivers a detailed analysis with 70 key tables, more than 74 visually impactful figures, and 165 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Microscope Type
  • 2.4. Snippet by Application
  • 2.5. Snippet by End User
  • 2.6. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Advancements in Imaging and Display Technologies
      • 3.1.1.2. Increasing Need for 3D Visualization and Analysis
    • 3.1.2. Restraints
      • 3.1.2.1. High Cost of Implementation
      • 3.1.2.2. Technical Challenges and Limitations
    • 3.1.3. Opportunity
      • 3.1.3.1. Integration with Augmented Reality (AR) and Virtual Reality (VR)
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest largest-selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Force Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. By Microscope Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Microscope Type
    • 5.1.2. Market Attractiveness Index, By Microscope Type
  • 5.2. Transmission DHM*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Reflection DHM
  • 5.4. Off-axis DHM
  • 5.5. Inline DHM

6. By Application

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 6.1.2. Market Attractiveness Index, By Application
  • 6.2. Life Sciences*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Material Sciences
  • 6.4. Semiconductors
  • 6.5. Microelectronics
  • 6.6. Others

7. By End User

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 7.1.2. Market Attractiveness Index, By End User
  • 7.2. Academic & Research Institutes*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Pharmaceutical & Biotechnology Companies
  • 7.4. Hospitals & Clinics
  • 7.5. Manufacturing Industries

8. Regional Market Analysis and Growth Opportunities

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 8.1.2. Market Attractiveness Index, By Region
  • 8.2. North America
    • 8.2.1. Introduction
    • 8.2.2. Key Region-Specific Dynamics
    • 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Microscope Type
    • 8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.2.6.1. U.S.
      • 8.2.6.2. Canada
      • 8.2.6.3. Mexico
  • 8.3. Europe
    • 8.3.1. Introduction
    • 8.3.2. Key Region-Specific Dynamics
    • 8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Microscope Type
    • 8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.3.6.1. Germany
      • 8.3.6.2. U.K.
      • 8.3.6.3. France
      • 8.3.6.4. Spain
      • 8.3.6.5. Italy
      • 8.3.6.6. Rest of Europe
  • 8.4. South America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Microscope Type
    • 8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.4.6.1. Brazil
      • 8.4.6.2. Argentina
      • 8.4.6.3. Rest of Latin America
  • 8.5. Asia-Pacific
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Microscope Type
    • 8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.5.6.1. China
      • 8.5.6.2. India
      • 8.5.6.3. Japan
      • 8.5.6.4. South Korea
      • 8.5.6.5. Rest of Asia-Pacific
  • 8.6. Middle East and Africa
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Microscope Type
    • 8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

9. Competitive Landscape and Market Positioning

  • 9.1. Competitive Overview and Key Market Players
  • 9.2. Market Share Analysis and Positioning Matrix
  • 9.3. Strategic Partnerships, Mergers & Acquisitions
  • 9.4. Key Developments in Product Portfolios and Innovations
  • 9.5. Company Benchmarking

10. Company Profiles

  • 10.1. Lyncee Tec*
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio
      • 10.1.2.1. Product Description
      • 10.1.2.2. Product Key Performance Indicators (KPIs)
      • 10.1.2.3. Historic and Forecasted Product Sales
      • 10.1.2.4. Product Sales Volume
    • 10.1.3. Financial Overview
      • 10.1.3.1. Company Revenue's
      • 10.1.3.2. Geographical Revenue Shares
      • 10.1.3.3. Revenue Forecasts
    • 10.1.4. Key Developments
      • 10.1.4.1. Mergers & Acquisitions
      • 10.1.4.2. Key Product Development Activities
      • 10.1.4.3. Regulatory Approvals, etc.
    • 10.1.5. SWOT Analysis
  • 10.2. Holoxica Limited
  • 10.3. Phase Holographic Imaging AB
  • 10.4. Ovizio Imaging Systems
  • 10.5. Nanolive SA
  • 10.6. Holmarc Opto-Mechatronics Ltd
  • 10.7. DAEIL SYSTEMS CO., LTD

LIST NOT EXHAUSTIVE

11. Assumptions and Research Methodology

  • 11.1. Data Collection Methods
  • 11.2. Data Triangulation
  • 11.3. Forecasting Techniques
  • 11.4. Data Verification and Validation

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us